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ABSTRACT
Hepatitis C virus (HCV) infection has quite high prevalence in the prison system, reaching rates of up to 40%. This survey aimed to estimate the 
prevalence of HCV infection and evaluate risk factors for this exposure among male inmates at the Ribeirão Preto Prison, State of São Paulo, Brazil, 
between May and August 2003. A total of 333 participants were interviewed using a standardized questionnaire and underwent immunoenzymatic 
assaying to investigate anti-HCV. The prevalence of HCV infection among the inmates was 8.7% (95% CI: 5.7-11.7). The participants’ mean age was 
30.1 years, and the prevalence was predominantly among individuals over 30 years of age. Multivariate analysis showed that the variables that were 
independently associated with HCV infection were age > 30 years, tattooing, history of previous hepatitis, previous injection drug use and previous 
needle-sharing.
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RESUMO
Infecção pelo vírus da hepatite C no sistema prisional apresenta elevada prevalência, chegando a atingir cifras superiores a 40%.  Esta pesquisa 
objetivou estimar a prevalência do HCV e avaliar fatores de risco para esta exposição na população masculina carcerária da Penitenciária de Ribeirão 
Preto – SP, no período de maio a agosto de 2003. Um total de 333 participantes foi submetido à aplicação de um questionário padronizado e a ensaio 
imunoenzimático para pesquisa de anti-HCV. A prevalência encontrada de infecção pelo HCV nos presidiários foi de 8,7% (IC 95%: 5,7-11,7). A média 
de idade dos participantes foi de 30,1 anos, com a prevalência predominando nos indivíduos acima de 30 anos. Na análise multivariada, as variáveis 
que se mostraram associadas de forma independente à infecção pelo HCV foram idade > 30 anos, tatuagem, história prévia de hepatite, passado de 
uso de droga injetável e passado de compartilhamento de agulhas.
Palavras-chaves: Hepatite C. Prisões. Prevalência. Fatores de risco. 
The inmate population is considered to be at high risk of 
infections such as human immunodeficiency virus (HIV), hepatitis 
B, hepatitis C and sexually transmitted diseases (STDs), because 
of the imprisonment conditions. Moreover, factors such as 
marginalization, drug addiction, low socioeconomic level and the 
precarious condition of the healthcare system in Brazil contribute 
towards dissemination of these diseases in prisons17. 
Investigations on the impact of hepatitis C within the prison 
system started before serological tests for hepatitis C virus (HCV) 
diagnosis were available, in 1985 and 1987, when Brewer 
et al5 investigated HIV transmission among inmates. A few years 
later, Vlahov et al25 analyzed stored serum samples from these 
two studies, and found an HCV infection rate of 38.1%, with an 
incidence of 1.1 per 100 individuals/year. 
In the United States, the prevalence of HCV infection in prisons 
is estimated to be between 15% and 30%, which indicates a 
rate as much as 20 times higher than the rate found among the 
general population4. High frequencies of viral infection have also 
been described in England (7%)26, Norway (46%)13 and Ghana 
(19.2%)1. In Brazil, studies carried out at different times have 
revealed prevalences ranging from 6.3% to 41%7 12 18. 
 Taken together, these figures highlight the urgent need to 
implement prevention programs directed towards prison settings, 
in order to prevent or reduce the transmission of viral infection 
during incarceration. The aim of this study was to estimate the 
prevalence of HCV infection and to assess the main risk factors 
among a male inmate population at the Ribeirão Preto Prison, 
State of São Paulo, Brazil. 
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MATERIAL AND METHODS
Study population. The prison in Ribeirão Preto has four 
closed and one semi-open confinement pavilions. In May 2003, 
nearly 1,030 prisoners were incarcerated. To estimate the sample 
size for this study, all 893 inmates under a closed confinement 
regime were used as the reference population. A minimum 
sample size of 322 subjects was calculated by assuming an HCV 
seroprevalence of 30%, 5% precision and a 95% confidence 
interval.
Data collection procedures. A simple random sampling 
procedure was used to select participants. One hundred inmates 
from each of the four closed-regime pavilions were selected at 
random. All the selected inmates who agreed to participate in this 
study signed a consent statement. The data and blood collections 
were carried out from May to August 2003. Each participant 
answered a questionnaire that sought demographic data and 
information on the length of time in prison and the following 
risk factors for HCV exposure: use of both intravenous and non-
intravenous illegal drugs, tattoos, sexual orientation and blood 
transfusions. All the questionnaires were applied by the same 
investigator. This project was approved by the Research Ethics 
Committee of the Clinical Hospital of Ribeirão Preto School of 
Medicine, University of São Paulo.
Laboratory testing. Anti-HCV was detected in blood samples 
by means of a commercial immunoenzymatic assay (Bioelisa HCV, 
Biokit, Spain). Initially reactive samples were retested in duplicate 
and the final result consisted of concordant results from at least 
two replicates. 
Statistical analysis. All data were entered into the Epi Info 
6.04 software, and were subsequently transported to the STATA 
9.0 statistical package. Chi-square and Fisher’s exact tests were 
used to assess associations between demographic/epidemiological 
variables and HCV infection. Multiple logistic regressions were 
performed for variables presenting a p value less than or equal 
to 0.25 in the univariate analysis14. 
RESULTS
Out of 345 inmates who answered the questionnaire 
and signed the consent statement, 12 refused to give a blood 
sample. Effectively, 333 individuals who allowed blood collected 
and answered the questionnaire took part in the study. The 
participants’ ages ranged from 19 to 69 years, with mean and 
median of 30.1 years and 28 years, respectively. More than half 
of the subjects were born either in the city of Ribeirão Preto or in 
the neighboring region. Subjects born in other cities in the State 
of São Paulo or in other Brazilian states represented 24.6% and 
22.5% of the sample, respectively. The overall prevalence of HCV 
infection was 8.7% (95% CI: 5.7-11.7). 
Table 1 shows that the HCV prevalence was higher among 
individuals aged over 30 years. It ranged from 14.5% among those 
between 31 and 35 years of age to 20% among those between 36 
and 45 years of age (grouping the participants into two categories: 
TABLE 1
Hepatitis C virus prevalence according to age, certain risk factors and previous history 
of hepatitis and jaundice. Ribeirão Preto Prison, São Paulo, Brazil, 2003.
Variable Number HCV + Percentage p
Age (years)    
19-24 96 1 1.0 < 0.001
25-30 107 6 5.6 
31-35 55 8 14.5 
36-45 60 12 20.0 
> 45 15 2 13.3 
Tattoo    
yes 120 23 19.2 0.070
no 213 6 2.8 
Sexual preference    
heterosexual 332 28 8.4 0.080
homosexual 1 1 100.0 
Previous STD    
yes 114 16 14.0 0.020
no 219 13 5.9 
Previous use of illegal non-injection drugs    
yes 271 29 10.7 < 0.001
no 62       -      - 
Previous use of illegal injection drugs    
yes, with needle sharing  11 8 72.7 < 0.001
yes, without needle sharing  18 5 27.8 
no 304 16 5.3 
Sex with illegal drug user    
yes 152 18 11.8 0.060
no  181 11 6.1 
Previous hepatitis    
yes 27 8 29.6 < 0.001
no 306 21 6.9 
Previous jaundice    
yes 24 6 25.0 0.010
no 309 23 7.4 
Total 333 29 8.7 
HCV: hepatitis C virus, STD: sexually transmitted disease.
under 30 and over 30 years: p < 0.001). Concerning medical 
history, the inmates who reported previous hepatitis, jaundice 
and STDs also showed higher frequencies of HCV. Only one inmate 
reported having had sex with other men, thus making it difficult 
to assess the association between this variable and HCV. Marginal 
statistical associations were found among those who reported 
having had heterosexual intercourse with illegal drug users (p = 
0.06) and having undergone tattooing (p = 0.07). On the other 
hand, previous non-intravenous illegal drug abuse was strongly 
associated with HCV (p < 0.001).
HCV infection was significantly higher among injection drug 
users (IDUs), compared with individuals who did not inject drugs 
(p < 0.001). Among IDUs, the positive rate was much higher 
among inmates who shared needles (72.7%), compared with 
those who did not (27.8%).
After multiple logistic regression analysis (Table 2), the 
variables identified as independent predictors for HCV infection 
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TABLE 2
Final logistic regression model for variables associated with hepatitis C virus infection. 
Ribeirão Preto Prison, São Paulo, Brazil, 2003.
Variable Odds ratio 95% CI p
Age > 30 years 7.3  2.4 – 21.3 0.00
Previous hepatitis 3.8  1.1 – 12.9 0.03
Tattoo 3.2  1.05 – 10.0 0.04
IDUs who did not share needles 4.1  1.1 – 14.2 0.03
IDUs who shared needles 48.8  9.3 –  254.5 0.00
95% CI: 95% confidential interval, IDUs: injection drug users
were: age above 30 years (OR = 7.3; 95% CI: 2.4-21.3), previous 
history of hepatitis (OR = 3.8; 95% CI: 1.1-12.9), having a 
tattoo (OR = 3.2; 95% CI: 1.05-10.0), previous injection drug 
use without needle-sharing (OR = 4.1; 95% CI: 1.1-14.2) and 
previous injection drug use with needle-sharing (OR = 9.3; 95% 
CI: 9.3-254.5).
DISCUSSION
Worldwide, the prevalence of hepatitis C reported in prisons 
is generally high, regardless of the regions in which studies were 
conducted, with 34.3% and 32.1%  in the United States10 16; 21.8% 
in Dublin, Ireland15; 10% in Durango, Mexico3; 30% in Hamedan, 
Iran2 and 16.6% in Quebec, Canada22. 
In Brazil, the first reports on the impact of hepatitis C among 
incarcerated populations were produced from two different 
studies in 1993 and 1994, carried out in Carandiru prison18 and 
Casa de Detenção12 in São Paulo. Both reports described very high 
prevalences of HCV infection, with rates reaching 34% and 41%, 
respectively. However, more recent investigations conducted in 
Minas Gerais and São Paulo over the last few years, have reported 
lower prevalences than those of the first reports: 6.3%7 and 6.0%6, 
respectively, i.e. much closer to our findings. 
Older age has been associated with HCV infection in different 
settings. In Brazil, about half of the hepatitis C cases notified 
(51.7%) between 2001 and 2006 were within the age range 
from 40 to 59 years23. This corroborates our results, in which 
a prevalence of 48.3% was found among subjects older than 36 
years (14 cases). However, different results (i.e. higher risk among 
young individuals) were found by Guimarães et al12, who reported 
that age under 28 was a risk factor for HCV, and by Pallás et al21, 
who showed a higher proportion of infected subjects between 26 
and 30 years of age (32%). 
Inmates present higher risk of STDs, compared with the general 
population, possibly because of their different behavioral patterns 
and general hygiene practices. In the present study, previous 
history of STDs was significantly associated with HCV infection in 
univariate analysis. However, this factor was not considered to be 
an independent predictor for viral infection, thus suggesting that 
there must be other factors that confound the relationship between 
these two variables. It is also important to take into account the 
small number of inmates who reported ulcerative STDs and the low 
efficiency of sexual transmission of HCV. 
There have been reports of sexual contact among inmates, 
especially associated with injection drug use11. However, such 
behavior was not observed in the present study. Apart from 
the stigma involved, which may have caused the prisoners to 
deny such practices, inmates who were transvestites or male 
sex professionals were preferentially incarcerated in the “safe” 
area, which houses those who need to be isolated from the other 
inmates for safety reasons. Since the inmates in the “safe” area 
were excluded from this study, we were unable to adequately 
analyze this issue.
Univariate and multivariate analysis did not demonstrate any 
association between HCV presence and sexual intercourse with 
illegal drug users. This finding was also observed by Adjei et al1, 
and one possible explanation for this could be the low efficiency 
of transmission of this virus through sexual intercourse.
In the present study, non-injection drug use and HCV infection 
were significantly associated in univariate analysis. There is a 
constant link between the inmate population and the use of such 
substances, since their use is considered to be a criminal offense in 
Brazil. Among intranasal users of illegal drugs, HCV presence may 
be associated with sharing the instrument used for drug intake9. 
Drug abuse (especially cocaine) damages the nasal mucosa and 
bleeding episodes when using the same instrument may favor 
viral transmission. However, the causal pathway to infection still 
remains unclear.
Injection drug use is considered to be the greatest risk for 
HCV infection, worldwide22 26. In our study, inmates who reported 
previous use of intravenous illegal drugs showed significantly 
higher frequencies of infection, especially among those who 
reported needle-sharing. These results are in consonance with 
the literature, which shows that HCV infection occurs shortly after 
starting to use intravenous drugs, and even earlier than hepatitis 
B virus (HBV) or HIV infections27. Furthermore, the literature 
shows that needle-sharing is a key risky behavioral pattern for 
HCV transmission among injection drug users20.
Inmates who presented tattoos were more likely to be infected 
than their non-tattooed counterparts were. It is important to 
emphasize that the risk of HCV infection through tattooing could 
be even higher when it is done inside the prison institution. In 
such settings, tattooing involves the use of tools and objects without 
even minimal hygiene conditions, thereby favoring infection by 
different pathogens, especially those that present high efficiency 
of parenteral transmission, like HCV24.
The results from this study and from other studies carried 
out over recent years6 7 indicate that the HCV prevalence among 
prisoners in Brazil seems to be declining, in comparison with 
fifteen years ago. The greater specificity of more recent laboratory 
tests may partially explain these differences. The possible reasons 
for the apparent reduction in HCV infection include the impact 
caused by campaigns against HIV in this particular prison, through 
the Ribeirão Preto Municipal Program for STD/AIDS8 and, most 
notably, the observed replacement of injectable cocaine (which 
was very popular some years ago) by the consumption of crack, 
which has become an important form of cocaine addiction more 
recently19.
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 Nevertheless, the findings from this study show that hepatitis 
C is still an important health problem within the Brazilian prison 
system. They indicate that viral transmission can be associated with 
several factors and behavioral patterns, such as the socioeconomic 
origin of the inmates, and frequently with risky practices like 
tattooing, needle-sharing for injection drug use and multiple 
unprotected sexual intercourse, within an unfavorable institutional 
environment. This information is pivotal for tailoring prevention 
programs and guiding specific socioeducational measures that 
aim to reduce or prevent HCV transmission within the prison 
setting. However, data on viral hepatitis among inmates is still 
very scarce in Brazil, and this points out the need for continuous 
epidemiological studies aimed at monitoring infection and 
directing prevention.
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